MediciNova Payables Turnover from 2010 to 2024

MNOV Stock  USD 2.17  0.01  0.46%   
MediciNova Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover will likely drop to 0.55 in 2024. Payables Turnover is a liquidity ratio that shows how quickly MediciNova pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
0.58
Current Value
0.55
Quarterly Volatility
0.27436903
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.9 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
  
Check out the analysis of MediciNova Correlation against competitors.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

Latest MediciNova's Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of MediciNova over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. MediciNova's Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Pretty Stable
   Payables Turnover   
       Timeline  

MediciNova Payables Turnover Regression Statistics

Arithmetic Mean0.27
Geometric Mean0.15
Coefficient Of Variation102.12
Mean Deviation0.23
Median0.16
Standard Deviation0.27
Sample Variance0.08
Range0.9129
R-Value0.14
Mean Square Error0.08
R-Squared0.02
Significance0.62
Slope0.01
Total Sum of Squares1.05

MediciNova Payables Turnover History

2024 0.55
2023 0.58
2021 0.5
2020 0.0346
2019 0.0531
2018 0.042
2017 0.0185

About MediciNova Financial Statements

MediciNova investors use historical fundamental indicators, such as MediciNova's Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Payables Turnover 0.58  0.55 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.